These offbeat classics, picked by people working in key sectors, can act as spiritual guidebooks, revealing the subtler ...

Despite the real problems with the additional indication being sought for suzetrigine, this drop in the stock is still an ...

Vertex Pharmaceuticals announced FDA approval for Alyftrek, which expands the company's CF franchise to address around 6,000 ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s ...

Needham & Company LLC reaffirmed their hold rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a ...

Other equities research analysts have also issued reports about the company. Morgan Stanley raised their price objective on Vertex Pharmaceuticals from $473.00 to $476.00 and gave the stock an ...

Vertex Pharmaceuticals (VRTX ... we can consider positive estimate revisions a sign of optimism about the company's business outlook. Research indicates that these estimate revisions are directly ...

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a modest uptick, ending the day at $408.18 which represents a slight increase of $2.91 or 0.72% from the prior close of $405.27. The stock opened at $401.53 ...

Vertex Pharmaceuticals (NASDAQ ... Judging by the results, the company may not have a winner on its hands. The candidate is already being considered for approval by regulators at the Food and ...

Vertex Pharmaceuticals is trying to diversify its ... Judging by the results, the company may not have a winner on its hands. The candidate is already being considered for approval by regulators ...